Trazimera
trastuzumab-qyyp · KIT · Pfizer Laboratories Div Pfizer Inc
No Recall History
Plain English
Trazimera is a kit containing trastuzumab-qyyp. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- Trazimera
- Generic Name
- trastuzumab-qyyp
- NDC Code (Product)
0069-0305- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA761081
- Drug Class
- HER2/neu Receptor Antagonist [EPC]
- Marketing Start
- 02/24/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Trazimera used for?
Trazimera contains trastuzumab-qyyp. It is a kit taken as directed. Consult your doctor for specific uses.
Is Trazimera a controlled substance?
Trazimera is not classified as a controlled substance by the DEA.
What is the generic name for Trazimera?
The generic name for Trazimera is trastuzumab-qyyp. There are no other listed brand versions of trastuzumab-qyyp.
What is the NDC code for Trazimera ?
The NDC (National Drug Code) for Trazimera is 0069-0305, listed by Pfizer Laboratories Div Pfizer Inc.
Other Trazimera Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)